✦ LIBER ✦

PCV15 ECONOMIC EVALUATION OF GLYCOPROTEIN IIB/IIIA ANTAGONISTS IN DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS WITH STENTING

✍ Scribed by N Mittmann; A Brown; SJ Seung; H Noorani; S Mensinkai; E Cohen; N Risebrough; P Oh; Z Tang

Book ID: 119593298
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62381-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GPIIb–IIIa antagonists reduce thromboinf

GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

✍ M. I. FURMAN; L. A. KRUEGER; M. D. LINDEN; M. L. FOX; S. P. BALL; M. R. BARNARD; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Assessment of use of Glycoprotein IIb/II

Assessment of use of Glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions

✍ K.J. Shah*; K.H. Parikh; M.C. Chag; U.G. Shah; A.H. Chandarana; H.A. Baxi; A.M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Use of IIb/IIIa inhibitors in patients w

Use of IIb/IIIa inhibitors in patients with acute coronary syndromes who do not undergo percutaneous coronary intervention

✍ Mardi Gomberg-Maitland; Jonathan L Halperin 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Optimal Use of Platelet Glycoprotein IIb

Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

✍ H. Benjamin Starnes, Ankit A. Patel, Dr George A. Stouffer 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 245 KB

Stenting and glycoprotein IIb/IIIa inhib

Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)

✍ Gilles Montalescot; Frans Van de Werf; Dietrich C. Gulba; Álvaro Avezum; David B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## Abstract Stenting and GP IIb/IIIa inhibition are promising adjunctive therapies in PCI. The Global Registry of Acute Coronary Events (GRACE) is a registry of unselected patients with acute coronary syndromes, allowing for the study of treatments in a real‐world environment. Data from GRACE patie

Platelet glycoprotein IIb/IIIa antagonis

Platelet glycoprotein IIb/IIIa antagonists are beneficial in patients with acute coronary syndromes who undergo in-hospital coronary artery bypass surgery

✍ Marco Roffi; David J Moliterno; Michael S Lauer; Joel Reginelli; Gang Jia; Eric 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 300 KB